Pharmacy

Richmond Pharmacology has integrated MHRA-licensed pharmacies located within each of their trial centres.

The pharmacies have been designed, commissioned and are operated in compliance with MHRA best practice and GMP guidelines.

The pharmacies are temperature controlled throughout and are connected to a sophisticated ‘auto-dialler’ alarm system. Richmond Pharmacology has the ability to store IMPs in a wide range of conditions to meet a sponsor’s requirements. Ambient and storage temperatures are continuously monitored and all temperature data is exported and signed off electronically. Stored temperature logs are available upon request.

Richmond Pharmacology pharmacies are staffed by 3 pharmacists with extensive experience of IMP preparation and dispensing for clinical trials. Pharmacy supervision is under the control of 3 licensed QPs

Our full-service offering includes a broad array of services. Our experienced staff are able to accommodate additional requirements at the request of our sponsors.

Our offering includes:

  • Licensed for storage and dispensing of controlled drugs
  • Preparation of study specific Pharmacy Manuals
  • Generation of Randomisation Schedules and Code Break Envelopes
  • IMP label production
  • Assembly and repackaging
  • Manufacture of solid and liquid dosage forms
  • Batch QP Certification
  • Importation of IMPs from non-EU countries
  • At study close-out, IMP reconciliation and destruction or retention

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

Richmond Pharmacology listed in the Alantra Pharma Fast 50

July 13, 2021
Richmond has been included in a top 50 list of the UK’s fastest-growing, privately-owned pharmaceutical businesses. 
Read more

Richmond Pharmacology listed in the J.P. Morgan Top 200 Female Powered Businesses

June 29, 2021
J.P. Morgan has identified Richmond Pharmacology as a high-growth female-powered business in its annual 'Top 200 Female Powered Businesses' list 2021.
Read more

CRISPR-Cas9 in-vivo gene editing shows reduction in TTR after a single dose

June 29, 2021
Data produced through Intellia Therapeutic’s NTLA-2001 FIH clinical trial, conducted at Richmond Pharmacology, indicates a reduction in the faulty TTR protein after a single infusion. Results were presented by Professor Julian Gillmore at this year’s Peripheral Nerve Society Annual Meeting.
Read more